A consortium of 38 leading scientists spanning various disciplines has issued a stark warning regarding the potential creation of “mirror bacteria” – synthetic organisms with reversed molecular structures. This concept, while seemingly out of a science fiction plot, poses significant risks that coul
MilliporeSigma, the Life Science business of Merck KGaA in the U.S. and Canada, has announced a definitive agreement to acquire HUB Organoids Holding B.V. (HUB). This acquisition marks a significant step forward in enhancing their 2D and 3D cell culture portfolio with the innovative technology of
In the ever-evolving field of biotechnology, cell and gene therapy offer unprecedented potential to treat diseases once considered untreatable. However, recent evidence suggests that the conventional methods of culturing cells might be hindering progress. Researchers are now reconsidering the
The Europe Plant Cell Culture Equipment Market is poised for significant growth from 2024 to 2031. This article delves into the various facets of this burgeoning market, providing a comprehensive analysis that includes market dynamics, product segmentation, regional insights, competitive landscape,
In a strategic move to tackle severe blood cancers, Alanis Therapeutics (ATI) has teamed up with KBI Biopharma to enhance the development and manufacturing of ATI's preclinical antibody candidate, ATI-D1. This partnership aims to accelerate the treatment of myelodysplastic syndromes (MDS) and
The field of tissue engineering and regenerative medicine has witnessed a groundbreaking advancement with the development of the High-throughput Integrated Tissue Fabrication System for Bioprinting (HITS-Bio) by researchers from Penn State. This innovative technology promises to transform the
